SAN DIEGO–(BUSINESS WIRE)– Pathway Genomics, an innovative commercial-stage genomics company,
announced today that Kamal Adawi, Chief Financial Officer, will present
at the 28th Annual Piper Jaffray Healthcare Conference. This event will
be held at The Lotte New York Palace in New York City on Wednesday,
November 30, 2016 at 2:10 p.m. ET and the presentation will be made
publically available on Pathway.com and Pathway’s social media.
About Pathway Genomics
Founded in 2008, Pathway Genomics offers digital healthcare and genetic
testing. Based in San Diego, CA our CLIA and CAP accredited clinical
laboratory provides physicians and their patients in 40+ countries with
actionable and accurate precision healthcare information to improve
health and wellness. The company’s program with IBM Watson is a
smartphone app that merges artificial intelligence and deep learning
with personal genetic information. The app provides users with
personalized health and wellness information based on the individual’s
health history.
Pathway believes in the power of “genetics first” to help make
proactive, informed decisions about health and lifestyle. Our
physician-ordered tests include assays for diet and weight loss,
circulating tumor DNA (liquid biopsy), hereditary cancer,
pharmacogenomics and carrier screening. For more about Pathway Genomics,
visit www.pathway.com
and follow us on Facebook,
LinkedIn
and Twitter.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005749/en/
Contacts
Pathway Genomics
Investor Relations
Kamal Adawi, Chief
Financial Officer
858.900.3002
kamal.adawi@pathway.com
Source: Pathway Genomics
Cet article Pathway Genomics’ Chief Financial Officer, Kamal Adawi, to Present at
the 28th Annual Piper Jaffray Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.